title: A report from the American Society of Hypertension's 2012 annual scientific meeting and exposition (May 19-22, 2012 - New York, New York, USA).
abstract: Competing with the AIDS walk held on Sunday May 20, 2012, the 2012 Annual Scientific Meeting and Exposition of the American Society of Hypertension was held in New York. Sitting through oral presentations and standing by posters was a scientifically rewarding task to get the most updated news on the management of high blood pressure and related cardiovascular risk determinants. The following report aims at summarizing clinical and preclinical findings reported during the meeting that have a direct impact on how hypertension and the cardiovascular risk is, should or could possibly be managed in the future.
authors: Thomson Reuters, Barcelona, Spain. xavier.rabasseda@thomsonreuters.com
authors: X
authors: X
authors: Rabasseda
mesh_terms: D000818:Animals; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects*; D002318:Cardiovascular Diseases / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control*; D004032:Diet; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D018570:Risk Assessment; D012307:Risk Factors; D040242:Risk Reduction Behavior; D016896:Treatment Outcome
chemical_list: D000959:Antihypertensive Agents; D004338:Drug Combinations